INFUGEM vs INLEXZO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	INFUGEM	INLEXZO
Rating	New	New
Pharmacy pays	~$599.88 /30	~$599.88 /30
Type	RX	RX
Active ingredient	GEMCITABINE HYDROCHLORIDE	GEMCITABINE HYDROCHLORIDE
Manufacturer	Sun Pharm	Janssen Biotech
Dosage forms	Solution	System
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

infugem inlexzo

Rating

New

Pharmacy pays

~$599.88 /30

Type

Active ingredient

GEMCITABINE HYDROCHLORIDE

Manufacturer

Sun Pharm

Janssen Biotech

Dosage forms

Solution

System

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms

Frequently asked questions

Which is cheaper, Infugem or Inlexzo?

Pharmacies pay about the same to acquire either one — roughly $599.88 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Infugem and Inlexzo?

Both Infugem and Inlexzo share the active ingredient Gemcitabine Hydrochloride.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.